David Bennett to Amyloidosis
This is a "connection" page, showing publications David Bennett has written about Amyloidosis.
Connection Strength
0.987
-
FMNL2 regulates gliovascular interactions and is associated with vascular risk factors and cerebrovascular pathology in Alzheimer's disease. Acta Neuropathol. 2022 07; 144(1):59-79.
Score: 0.207
-
Clinicopathologic Factors Associated With Reversion to Normal Cognition in Patients With Mild Cognitive Impairment. Neurology. 2022 05 17; 98(20):e2036-e2045.
Score: 0.204
-
Association Between Common Variants in RBFOX1, an RNA-Binding Protein, and Brain Amyloidosis in Early and Preclinical Alzheimer Disease. JAMA Neurol. 2020 10 01; 77(10):1288-1298.
Score: 0.185
-
Longitudinal Modeling of Functional Decline Associated with Pathologic Alzheimer's Disease in Older Persons without Cognitive Impairment. J Alzheimers Dis. 2018; 62(2):855-865.
Score: 0.153
-
Alzheimer's disease: early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci. Nat Neurosci. 2014 Sep; 17(9):1156-63.
Score: 0.121
-
3D mapping reveals network-specific amyloid progression and subcortical susceptibility in mice. Commun Biol. 2019; 2:360.
Score: 0.043
-
Sex-specific genetic predictors of Alzheimer's disease biomarkers. Acta Neuropathol. 2018 12; 136(6):857-872.
Score: 0.039
-
Entorhinal Cortex: Antemortem Cortical Thickness and Postmortem Neurofibrillary Tangles and Amyloid Pathology. AJNR Am J Neuroradiol. 2017 May; 38(5):961-965.
Score: 0.036